83-2270-07　［受注停止］GENLISA Human Anti-SARS-CoV-2 （Covid-19） IgG to spike RBD Omicron Variant （B.1.1.529） Quantitative TITRATION ELISA 1 x 96 wells　KBVH015-43

特徴

• Description：ELISA for quantitative estimation of Anti SARS-CoV-2 IgG antibodies to Spike RBD protein of the Omicron variant in human serum and plasma samples.
• The assay kit contains a SARS-CoV-2 Spike RBD Omicron Variant （B.1.1.529） protein Coated Microtiter Plate and Anti-SARS-CoV-2 Spike RBD Antibody （Omicron Reactive） as Standards in the kit.
• Why the RBD protein?
• The COVID-19 Omicron variant is by far the most divergent variant characterized by a high number of mutations in the spike protein.
• Several mutations （e.g., N501Y, P681H） have been identified in previous variants and are associated with increased transmissibility, immune escape, or other properties.
• There are a total of 30 amino acid changes： among which 15 are located in the RBD region of the virus.

仕様

• サイズ：1 x 96 wells
• Reactivity：Human
• アプリケーション：ELISA,Immunoassay
• Sensitivity：12 ng/ml
• Calibration Range：0-720 ng/ml
• サンプルタイプ：Serum and Plasma
• データシート：https://krishgen.com/upload/datasheets/KBVH015-43_GENLISA_Human_Anti-SARS-CoV-2_（Covid-19）_IgG_Antibody_to_spike_RBD_Omicron_Variant_（B_1_1_529）_protein_Quantitative_TITRATION_ELISA.pdf
• 測定方法：Colorimetric, 450nm
• この商品は法規制を確認しておりません。（法規制によって販売できない場合もございます）

• 【試薬に関するお問合せ】
• アズワン株式会社 試薬・プロセス材料グループ
• TEL：06-6447-8641
• FAX：06-6447-8642
• E-mail：[email protected]